2022-09-30T13:14:45-05:00 2021-12-31 861065772 DELOITTE TAX LLP 695 TOWN CENTER DRIVE SUITE 1000 COSTA MESA CA 92626 990 2021-01-01 980593375 GAVI ALLIANCE GAVI 41229096500 CHEMIN DU POMMIER 40 GRANDSACONNEX GENEVA SZ 1218 ASSIETOU DIOUF MANAGING DIR, FINANCE/OPER. 41229096500 2022-09-30 1 ASSIETOU DIOUF XXX-XX-XXXX JOHN W SADOFF JR P00540589 7144367100 3 AAL1 IAL1 2021 2022-09-23 18:48:47Z GAVI THE VACCINE ALLIANCE ASSIETOU DIOUF CHEMIN DU POMMIER 40 GRANDSACONNEX GENEVA SZ 1218 25153990377 0 X GAVI.ORG X 2009 SZ TO SAVE LIVES & PROTECT PEOPLE'S HEALTH BY INCREASING EQUITABLE AND SUSTAINABLE USE OF VACCINES. 44 44 18 58 0 0 2433703395 16367570660 0 0 22864796 72243278 -125399918 -42699804 2331168273 16397114134 2014115924 8455743099 0 0 57861874 63282276 0 0 23686064 44980640 62873137 2116958438 8581898512 214209835 7815215622 6896842127 16258481147 3389804483 4899555355 3507037644 11358925792 X TO SAVE LIVES AND PROTECT PEOPLE'S HEALTH BY INCREASING EQUITABLE AND SUSTAINABLE USE OF VACCINES. 0 0 6477073250 6468571381 THE FIRST COVAX-SUPPLIED VACCINE DOSES WERE ADMINISTERED IN A GAVI COVAX AMC COUNTRY ON 16 JANUARY 2021. DURING 2021, 1.2 BILLION DOSES WERE MADE AVAILABLE BY MANUFACTURERS FOR DELIVERY, APPROXIMATELY 600 MILLION FROM DONATIONS AND 600 MILLION FROM APAS. OF THESE 1.2 BILLION DOSES, COVAX DELIVERED 946.6 MILLION DOSES FROM SEVEN MANUFACTURERS TO 144 COVAX PARTICIPANTS, JUST OVER 500 MILLION THROUGH APAS AND 435 MILLION THROUGH DOSE SHARING. OF THESE 946.6 MILLION DOSES, 829 MILLION DOSES WERE DELIVERED TO 86 AMC PARTICIPANTS; AND 116 MILLION DOSES WERE DELIVERED TO 58 SELF-FINANCING PARTICIPANTS (SFPS). AN ADDITIONAL 1.6 MILLION DOSES WERE DELIVERED TO COVAX HUMANITARIAN BUFFER RECIPIENTS IN 2021.BY END 2021, SUPPLY DELIVERED THROUGH COVAX ENABLED AMC91 (I.E. EXCLUDING INDIA) TO ACHIEVE 13% COVERAGE WITH AT LEAST ONE DOSE; AND 10% COVERAGE WITH TWO DOSES.REFLECTING ON THE ACHIEVEMENTS OF 2021, IT'S CLEAR MANY OF THE GAINS WERE HARD WON, AND IT TOOK MUCH LONGER TO ACHIEVE THE DELIVERY MILESTONES THAN ORIGINALLY ANTICIPATED. ALTHOUGH COVAX WAS UNABLE TO DELIVER ON ITS INITIAL DOSE DELIVERY GOALS, DELIVERING 829 MILLION VACCINE DOSES TO AMC ECONOMIES (AGAINST A TARGET OF 950 MILLION) WAS A TREMENDOUS ACHIEVEMENT. YET INEQUITIES BETWEEN AMC ECONOMIES AND HIGHER-INCOME COUNTRIES REMAINED AT THE END OF 2021. THE FOLLOWING LESSONS HAVE DRIVEN CHANGES TO COVAX'S OPERATIONAL MODEL AND WILL GUIDE OUR APPROACH TO THE GAVI COVAX AMC IN 2022.FURTHER INFORMATION ON GAVI'S COVAX REPORT CAN BE FOUND IN ITS 2021 ANNUAL PROGRESS REPORT, ONLINE AT: HTTPS://WWW.GAVI.ORG/PROGRAMMES-IMPACT/OUR-IMPACT/PROGRESS-REPORTS. 2046562973 1987171718 THE VACCINE GOAL: INTRODUCE AND SCALE UP VACCINESIN 2021, GAVI-SUPPORTED COUNTRIES ADMINISTERED MORE VACCINES THAN ANY YEAR IN HISTORY.GAVI SUPPORTED 39 VACCINE INTRODUCTIONS AND CAMPAIGNS THIS YEAR AN INCREASE FROM 21 IN 2020. THE 57 GAVI-SUPPORTED COUNTRIES HAVE INCREASED COVERAGE OF THREE KEY SDG VACCINES SINCE 2019.IN 2021, EMERGENCY STOCKPILES FOR CHOLERA, EBOLA, MENINGOCOCCAL AND YELLOW FEVER VACCINES WERE ACCESSED A TOTAL OF 25 TIMES BY 14 COUNTRIES.GAVI'S UPDATED MEASURE OF BREADTH OF PROTECTION, WHICH NOW INCLUDES COVERAGE AGAINST POLIO ANDHPV, REACHED 51% IN 2021, UP 16 PERCENTAGE POINTS FROM 2019.THE EQUITY GOAL: STRENGTHEN HEALTH SYSTEMS TO INCREASE EQUITY IN IMMUNIZATIONIN GAVI 5.0, HEALTH SYSTEM STRENGTHENING (HSS) SUPPORT PRIORITISES EQUITY IN IMMUNIZATION DELIVERY, TO REDUCE THE NUMBER OF ZERO-DOSE AND UNDER-IMMUNIZED CHILDREN.COVID-19 PANDEMIC-RELATED DISRUPTIONS TO ROUTINE IMMUNIZATION CONTINUED IN 2021, LEADING TO DECLINES IN COVERAGE IN GAVI-SUPPORTED COUNTRIES. OVERALL, THE RATE OF DECLINE IN IMMUNIZATION COVERAGE IN GAVI-SUPPORTED COUNTRIES SLOWED IN 2021 COMPARED TO THE DECLINE SEEN IN 2020.2021 SAW A RECORD NUMBER OF COLD CHAIN PROCUREMENTS THROUGH UNICEF, INCLUDING FROM GAVI'S CCEOP AND COVAX.IN 2021, 6.3 MILLION IMMUNIZATION SESSIONS WERE CONDUCTED IN GAVI-SUPPORTED COUNTRIES.IN 2021, DTP3 AND MCV1 COVERAGE IN GAVI-SUPPORTED COUNTRIES WAS 77% (COMPARED TO THE 81% GLOBAL AVERAGE) A DECLINE FROM 2020 OF 1 PERCENTAGE POINT FOR DTP3 AND 2 PERCENTAGE POINTS FOR MCV1.THE SUSTAINABILITY GOAL: IMPROVE SUSTAINABILITY OF NATIONAL IMMUNIZATION PROGRAMMESTHE YEAR 2021 CONFIRMED THE ROBUSTNESS OF THE VACCINE ALLIANCE'S CO-FINANCING APPROACH AND THE STEADY FINANCIAL COMMITMENT OF COUNTRIES DESPITE THE COVID-19 PANDEMIC.A TESTAMENT TO INCREASING COUNTRY OWNERSHIP AND THE LONG-TERM FINANCIAL SUSTAINABILITY OF GAVI-SUPPORTED VACCINES, COUNTRIES CONTRIBUTED A RECORD US$ 161 MILLION TOWARDS THE CO-FINANCING OF GAVI-SUPPORTED VACCINES IN 2021 DESPITE THE ONGOING FISCAL CHALLENGES OF THE COVID-19 PANDEMIC.THE NUMBER OF VACCINE PROGRAMMES ORIGINALLY INTRODUCED WITH GAVI FUNDING, BUT WHICH ARE NOW SELF-FINANCED BY COUNTRIES, INCREASED FROM 40 IN 2018 TO 49 IN 2020 AND 2021.IN A CHALLENGING FISCAL CONTEXT, MOST GAVI-ELIGIBLE COUNTRIES WERE ABLE TO MAINTAIN OR INCREASE DOMESTICRESOURCES FOR CO-FINANCING OF GAVI-SUPPORTED VACCINES IN 2021, BRINGING TO US$ 1.3 BILLION THEIR TOTAL CONTRIBUTION SINCE THE INTRODUCTION OF THE CO-FINANCING POLICY IN 2008.THE MARKET SHAPING GOAL: ENSURE HEALTHY MARKETS FOR VACCINES AND RELATED PRODUCTSGAVI'S MARKET SHAPING EFFORTS MAKE LIFE-SAVING VACCINES AND OTHER IMMUNIZATION PRODUCTS MORE ACCESSIBLE AND AFFORDABLE FOR LOWER-INCOME COUNTRIESIN 2021, THE NUMBER OF MARKETS EXHIBITING ACCEPTABLE LEVELS OF HEALTHY MARKET DYNAMICS FOR VACCINES AND IMMUNIZATION PRODUCTS IMPROVED FROM 10 TO 11, EXCEEDING THE TARGET FOR THE YEAR.INNOVATION-RELATED MARKET SHAPING INDICATORS ARE LARGELY ON TRACK. THE NUMBER OF INNOVATIVE PRODUCTS WITHIN THE PIPELINE OF COMMERCIAL-SCALE MANUFACTURERS INCREASED BY TWO IN 2021.THE GAVI BOARD APPROVED GAVI'S MARKET SHAPING STRATEGY FOR THE GAVI 5.0 STRATEGIC PERIOD (MSS 5.0); AND SUPPORT FOR MALARIA VACCINE ROLL-OUT IN SUB-SAHARAN AFRICA.THROUGH GAVI'S MARKET SHAPING EFFORTS, THE NUMBER OF MANUFACTURERS SUPPLYING PREQUALIFIED GAVI-SUPPORTED VACCINES HAS GROWN FROM 5 IN 2001 TO 18 IN 2021 (WITH MORE THAN HALF BASED IN AFRICA, ASIA AND LATIN AMERICA).FURTHER INFORMATION ON GAVI'S PROGRESS TOWARDS ACHIEVING ITS STRATEGIC GOALS CAN BE FOUND IN ITS 2021 ANNUAL PROGRESS REPORT, ONLINE AT: HTTPS://WWW.GAVI.ORG/PROGRAMMES-IMPACT/OUR-IMPACT/PROGRESS-REPORTS. 8523636223 1 1 0 1 0 0 0 0 0 0 1 1 0 0 1 1 0 1 0 1 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 1 1 1 0 0 1 X 50 0 1 18 1 0 1 SZ NO EI LU 0 0 0 0 0 0 0 0 0 0 X 44 44 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 X ASSIETOU DIOUF 4122909650 CHEMIN DU POMMIER 40 GRANDSACONNEX GENEVA SZ 1218 X DR SETH BERKLEY CHIEF EXECUTIVE OFFICER 47.50 2.50 X 696465 0 117974 ANURADHA GUPTA DEPUTY CHIEF EXECUTIVE OFFICER 48.50 1.50 X 347767 0 88334 SIMON LAMB MNG DIR, AUDIT & INVESTIGATIONS 50.00 0.00 X 287682 0 74332 PASCAL BAROLLIER MANAGING DIR, PUBLIC ENGAGEMENT & IS 50.00 0.00 X 269886 0 86904 ALEX DE FAUQUE DE JONQUIERES DIR, HEALTH SYS. & IMMUNE. STRENGTH. 50.00 0.00 X 288088 0 65671 EDMUND GROVE DIRECTOR PROGRAMME AUDIT 50.00 0.00 X 281502 0 64005 ANDREW MENDS DIRECTOR OPERATIONS 50.00 0.00 X 280401 0 63668 MARIE-ANGE SARAKA-YAO MNG DIR, RESOURCE MOBL./PARTNERSHIPS 50.00 0.00 X 276172 0 67013 AURELIA NGUYEN MNG DIR OFFICE OF THE COVAX FACILITY 50.00 0.00 X 272535 0 69886 ANTHONY BROWN SENIOR LEGAL COUNSEL - UNTIL 05/2021 50.00 0.00 X 310795 0 19261 THABANI MAPHOSA MANAGING DIR, COUNTRY PROGRAMMES 50.00 0.00 X 252122 0 67002 BRENDA KILLEN DIRECTOR, GOVERNANCE 42.50 7.50 X 259036 0 58439 ASSIETOU DIOUF MANAGING DIR, FINANCE & OPERATIONS 47.50 2.50 X 234294 0 72396 JOSE MANUEL BARROSO CHAIR - FROM 01/2021 2.00 0.00 X 0 0 0 SARAH GOULDING VICE CHAIR 2.00 0.00 X 0 0 0 WILLIAM H ROEDY BOARD MEMBER - UNTIL 07/2021 2.00 0.00 X 0 0 0 MARGARET PEGGY HAMBURG BOARD MEMBER 2.00 0.00 X 0 0 0 HELEN REES BOARD MEMBER 2.00 0.00 X 0 0 0 TERESA RESSEL BOARD MEMBER 2.00 0.00 X 0 0 0 DAVID SIDWELL BOARD MEMBER 2.00 0.00 X 0 0 0 STEPHEN ZINSER BOARD MEMBER - UNTIL 06/2021 2.00 0.00 X 0 0 0 YIBING WU BOARD MEMBER 2.00 0.00 X 0 0 0 AWA MARIE COLL SECK BOARD MEMBER - FROM 07/2021 2.00 0.00 X 0 0 0 NAGUIB KHERAJ BOARD MEMBER - FROM 08/2021 2.00 0.00 X 0 0 0 ORIN LEVINE BOARD MEMBERS - UNTIL 11/2021 2.00 0.00 X 0 0 0 VIOLAINE MITCHELL BOARD MEMBER - FROM 12/2021 2.00 0.00 X 0 0 0 AFSANEH BESCHLOSS BOARD MEMBER 2.00 0.00 X 0 0 0 MUHAMMAD PATE BOARD MEMBER - UNTIL 06/2021 2.00 0.00 X 0 0 0 OMAR ABDI BOARD MEMBER 2.00 0.00 X 0 0 0 JUAN PABLO URIBE BOARD MEMBER - FROM 09/2021 2.00 0.00 X 0 0 0 ZSUZANNA JAKAB BOARD MEMBER 2.00 0.00 X 0 0 0 HARSH VARDHAN BOARD MEMBER - FROM 1/2021-8/2021 2.00 0.00 X 0 0 0 KWAKU AGYEMAN-MANU BOARD MEMBER - FROM 01/2021 2.00 0.00 X 0 0 0 MANSUKH MANDAVIYA BOARD MEMBER - FROM 09/2021 2.00 0.00 X 0 0 0 FAISAL SULTAN BOARD MEMBER - FROM 09/2021 2.00 0.00 X 0 0 0 ARSEN TOROSYAN BOARD MEMBER - UNTIL 01/2021 2.00 0.00 X 0 0 0 ASSAD HAFEEZ BOARD MEMBER - FROM 1/2021-4/2021 2.00 0.00 X 0 0 0 ANAHIT AVANYESAN BOARD MEMBER - FROM 03/2021 2.00 0.00 X 0 0 0 ABDOULAYE SABRE FADOUL BOARD MEMBER - UNTIL 12/2021 2.00 0.00 X 0 0 0 JOAN VALADOU BOARD MEMBER - FROM 01/2021 2.00 0.00 X 0 0 0 BETH ARTHY BOARD MEMBER 2.00 0.00 X 0 0 0 JOHN ARNE ROTTINGEN BOARD MEMBER - FROM 01/2021 2.00 0.00 X 0 0 0 ROGER CONNOR BOARD MEMBER 2.00 0.00 X 0 0 0 MAHIMA DATLA BOARD MEMBER 2.00 0.00 X 0 0 0 MATY DIA BOARD MEMBER 2.00 0.00 X 0 0 0 MARTA NUNES BOARD MEMBER 2.00 0.00 X 0 0 0 MEGAN CAIN BOARD MEMBER - FROM 01/2021 2.00 0.00 X 0 0 0 ALAA MURABIT ALTERNATE BOARD MEMBER - FROM 12/21 2.00 0.00 X 0 0 0 LIA TADESSE ALTERNATE BOARD MEMBER - FROM 01/21 2.00 0.00 X 0 0 0 MICHAEL KENT RANSON ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 ETLEVA KADILLI ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 KATE O'BRIEN ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 BOUNKONG SYHAVONG ALTERNATE BOARD MEMBER - UNTIL 06/21 2.00 0.00 X 0 0 0 BOUNFENG PHOUMMALAYSITH ALTERNATE BOARD MEMBER - FROM 07/21 2.00 0.00 X 0 0 0 JACQUELINE LYDIA MIKOLO ALTERNATE BOARD MEMBER - UNTIL 07/21 2.00 0.00 X 0 0 0 GILBERT MOKOKI ALTERNATE BOARD MEMBER - FROM 07/21 2.00 0.00 X 0 0 0 HANNAH HAAIJ ALTERNATE BOARD MEMBER - UNTIL 01/21 2.00 0.00 X 0 0 0 JORIS JURRIENS ALTERNATE BOARD MEMBER - FROM 02/21 2.00 0.00 X 0 0 0 SUSAN ELDEN ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 SAAD OMER ALTERNATE BOARD MEMBER - FROM 01/21 2.00 0.00 X 0 0 0 WAHID MAJROOH ALT. BOARD MEMBER - FROM 02/21-08/21 2.00 0.00 X 0 0 0 EDNA YOLANI BATRES ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 FRANCESCA MANNO ALTERNATE BOARD MEMBER - FROM 01/21 2.00 0.00 X 0 0 0 CARMEN COLES TULL ALTERNATE BOARD MEMBER - UNTIL 05/21 2.00 0.00 X 0 0 0 JEREMY KONYNDYK ALTERNATE BOARD MEMBER - FROM 05/21 2.00 0.00 X 0 0 0 KEIICHI ONO ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 AN VERMEESCH ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 BERNHARD BRAUNE ALTERNATE BOARD MEMBER - FROM 01/21 2.00 0.00 X 0 0 0 XIANG SHU ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 AHMAD JAWAD OSMANI ALTERNATE BOARD MEMBER - UNTIL 02/21 2.00 0.00 X 0 0 0 RAFAEL VILASANJUAN ALTERNATE BOARD MEMBER 2.00 0.00 X 0 0 0 4056745 0 914885 246 0 1 0 HELVETIC PAYROLL SA RUE DU LAUSANNE 44 1201 GENEVA SZ TEMPORARY STAFFING 5537069 LINKLATERS LLP 1 ONE SILK STREET LONDON UK EC2Y 8HQ LEGAL SERVICES 2906824 TECH MAHINDRA LIMITED OFF KARVE ROAD PUNE IN 411004 IT SERVICES 2419504 MCKINSEY AND COMPANY INC BLEICHERWEG 20 8002 ZURICH SZ CONSULTING SERVICES 2090444 THE BOSTON CONSULTING GROUP AND CIE BLEICHERWEG 62 8002 ZURICH SZ CONSULTING SERVICES 1907133 160 1449477500 13197193142 1720900018 4406723991 16367570660 11257940 11257940 8817861581 8756876243 60985338 60985338 60985338 OTHER INCOME 900099 186856 186856 FC TRANSLATION ADJ. 900099 -42886660 -42886660 -42699804 16397114134 0 0 29543474 93642092 93642092 8362101007 8362101007 3236225 2006460 679607 550158 40308163 25095537 8282781 6929845 8387319 5221770 1723666 1441883 10371684 6456007 2133539 1782138 978885 609292 201416 168177 2799835 2799835 399599 399599 227200 227200 1389035 1389035 40591312 19652166 11111280 9827866 677363 277728 24750 374885 5909073 3207012 1898098 803963 3366841 2225690 592996 548155 3076058 1669460 988084 418514 809571 483508 263797 62266 1058365 215771 201136 641458 705972 383150 226771 96051 299180 162373 96102 40705 TRAINING & RECRUITMENT 1563733 1563733 8581898512 8523636223 34576225 23686064 X 26133990 17272200 4624344 4237446 99277038 1264065924 3187411270 5786704150 1475819226 3099817956 351028735 4263399020 8639078 6291239 1938033 2347839 1326662408 1241567725 454705417 600578533 6896842127 16258481147 17946918 57988019 117860164 59080922 127112753 416512779 0 500280000 3126884648 3865693635 3389804483 4899555355 X 1643920333 5218171172 1863117311 6140754620 3507037644 11358925792 6896842127 16258481147 X 7815215622 16897476 19775050 X 0 1 X 1 0 X 614655000 596158662 800186577 2433703395 16367570660 20812274294 614655000 596158662 800186577 2433703395 16367570660 20812274294 3059357469 17752916825 17988337 29223123 31105860 16200090 11257940 105775350 542556 430236 274962 27180 186856 1461790 20919511434 0.84860 0.86920 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2017 AMOUNT: $ 407,132. 2018 AMOUNT: $ 295,261. 2019 AMOUNT: $ 266,165. 2020 AMOUNT: $ 27,180. 2021 AMOUNT: $ 186,856. PARKING FEES - 2017 AMOUNT: $ 135,424. 2018 AMOUNT: $ 134,975. 2019 AMOUNT: $ 8,797. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 1 277200 0 0 277200 0 PART II-B, LINE 1: FEES WERE PAID FOR: 1. PRESENTATION AND OUTREACH TO MEMBERS OF THE CONGRESS AND STAFF OF THE HOUSE AND SENATE COMMITTEES ON APPROPRIATIONS, AND ANY OTHER COMMITTEES NEEDED, TO REQUEST SUPPORT FOR THE GAVI ALLIANCE; AND 2. SUPPORT AND GUIDANCE TO GAVI ALLIANCE IN POSITIONING THE ORGANIZATION WITH THE ADMINISTRATION, AND OUTREACH TO MEMBERS OF THE CONGRESS AND STAFF ON VARIOUS COMMITTEES. 1185226 474050 711176 1036155 682723 353432 6417697 5134466 1283231 2347839 LIMITED LIABILITY COMPANIES AND LIMITED PARTNERSHIPS 873894445 F REGISTERED INVESTMENT COMPANIES 367673280 F 1241567725 PROCUREMENT ACCOUNTS PAYABLE 1836993874 OPERATING LEASE OBLIGATION 21654308 FOREIGN CURRENCY FORWARD CONTRACTS PAYABLE 47888178 REFUNDABLE ADVANCE 300000000 PAYABLE ON COVAX FACILITY ARRANGEMENTS 1659157275 3865693635 X PART X, LINE 2: GAVI IS EXEMPT FROM INCOME TAXES IN EACH OF THE JURISDICTIONS IN WHICH IT HAS OPERATIONS. US GAAP REQUIRES THAT FINANCIAL STATEMENTS REFLECT THE EXPECTED FUTURE TAX CONSEQUENCES OF UNCERTAIN TAX POSITIONS THAT AN ENTITY HAS TAKEN OR EXPECTS TO TAKE ON A TAX RETURN, PRESUMING THE TAX AUTHORITIES' FULL KNOWLEDGE OF THE POSITION AND ALL RELEVANT FACTS. US GAAP ALSO REQUIRES THAT AN ENTITY RECOGNISE THE BENEFIT OF TAX POSITIONS WHEN IT IS MORE LIKELY THAN NOT THAT THE PROVISION WILL BE SUSTAINABLE BASED ON THE MERITS OF THE POSITION. GAVI PERFORMED AN EVALUATION OF UNCERTAIN TAX POSITIONS FOR THE YEARS ENDED 31 DECEMBER 2021 AND 2020 AND DETERMINED THAT THERE WERE NO MATTERS THAT WOULD REQUIRE RECOGNITION IN THE FINANCIAL STATEMENTS OR WHICH MAY HAVE ANY EFFECT ON ITS TAX-EXEMPT STATUS. AS OF 31 DECEMBER 2021, THE STATUTES OF LIMITATIONS FOR TAX YEARS 2018 THROUGH 2020 REMAIN OPEN WITH THE UNITED STATES FEDERAL JURISDICTION OR THE VARIOUS STATES AND LOCAL JURISDICTIONS IN WHICH GAVI FILES TAX RETURNS. IT IS GAVI'S POLICY TO RECOGNISE INTEREST OR PENALTIES RELATED TO UNCERTAIN TAX POSITIONS, IF ANY, IN INCOME TAX EXPENSE. AS OF 31 DECEMBER 2021 AND 2020, GAVI HAD NO ACCRUED INTEREST OR PENALTIES. 1 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 258976834 SUB-SAHARAN AFRICA - ANGOLA, BENIN, BOTSWANA, BURKINA FASO, 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 3886398411 SOUTH ASIA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 1679919512 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 1402032995 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 184426351 RUSSIA AND NEIGHBORING STATES 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 272481364 CENTRAL AMERICA AND THE CARIBBEAN 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 169161444 SOUTH AMERICA 0 0 GRANTS TO RECIPIENTS LOCATED IN REGION 53537289 VARIOUS REGIONS 0 0 GRANTS TO RECIPIENTS LOCATED IN VARIOUS REGIONS 455166807 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 INVESTMENTS 3758168445 EUROPE (INCLUDING ICELAND & GREENLAND) 1 300 PROGRAM SERVICES COUNTRY PROGRAMMES MGMT. & OVERSIGHT, POLICY & PERFORMANCE, AND OPERATIONS 67893124 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 FUNDRAISING 23686064 0 0 1 300 1 300 7906934200 4304914440 12211848640 SOUTH ASIA COUNTRY PROGRAMMES 12906281 BOARD APPROVAL/WIRE TRANSFER 80805789 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1725250 BOARD APPROVAL/WIRE TRANSFER 100868292 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 4298196 BOARD APPROVAL/WIRE TRANSFER 114813629 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 0 525333 VACCINE SUPPORT FMV SOUTH ASIA COUNTRY PROGRAMMES 14732809 BOARD APPROVAL/WIRE TRANSFER 350187609 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 3075491 BOARD APPROVAL/WIRE TRANSFER 40733143 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV SOUTH ASIA COUNTRY PROGRAMMES 460000 BOARD APPROVAL/WIRE TRANSFER 5392642 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SOUTH AMERICA COUNTRY PROGRAMMES 2200000 BOARD APPROVAL/WIRE TRANSFER 46292719 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 0 25200 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 4791498 BOARD APPROVAL/WIRE TRANSFER 183607655 VACCINE SUPPORT, YELLOW FEVER DIAG., COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 5944810 BOARD APPROVAL/WIRE TRANSFER 9471230 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 305600 BOARD APPROVAL/WIRE TRANSFER 1670257 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 1291523 BOARD APPROVAL/WIRE TRANSFER 29065675 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 6030764 BOARD APPROVAL/WIRE TRANSFER 26841154 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 5701108 BOARD APPROVAL/WIRE TRANSFER 53018168 VACCINE SUPPORT, YELLOW FEVER DIAG., COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 10442340 BOARD APPROVAL/WIRE TRANSFER 19620111 VACCINE SUPPORT, YELLOW FEVER DIAG., COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 656956 BOARD APPROVAL/WIRE TRANSFER 200706 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 17876655 BOARD APPROVAL/WIRE TRANSFER 40680298 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 17656565 BOARD APPROVAL/WIRE TRANSFER 84525478 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 3814273 BOARD APPROVAL/WIRE TRANSFER 65098559 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1128923 BOARD APPROVAL/WIRE TRANSFER 124811625 VACCINE SUPPORT & COLD CHAIN EQUIPMENT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 430000 BOARD APPROVAL/WIRE TRANSFER 907643 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 8281131 BOARD APPROVAL/WIRE TRANSFER 276963586 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 1606418 BOARD APPROVAL/WIRE TRANSFER 32810448 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 354014 BOARD APPROVAL/WIRE TRANSFER 2154693 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 465600 BOARD APPROVAL/WIRE TRANSFER 4129306 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 24272691 BOARD APPROVAL/WIRE TRANSFER 279528593 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 495200 BOARD APPROVAL/WIRE TRANSFER 4288639 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 0 76500 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 977007 BOARD APPROVAL/WIRE TRANSFER 5056187 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 3903612 BOARD APPROVAL/WIRE TRANSFER 86063431 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 430000 BOARD APPROVAL/WIRE TRANSFER 1189376 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 3047999 BOARD APPROVAL/WIRE TRANSFER 159027927 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1992375 BOARD APPROVAL/WIRE TRANSFER 4304516 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SOUTH AMERICA COUNTRY PROGRAMMES 1010600 BOARD APPROVAL/WIRE TRANSFER 3313776 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 3264082 BOARD APPROVAL/WIRE TRANSFER 6104089 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 1534527 BOARD APPROVAL/WIRE TRANSFER 40479081 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV VARIOUS REGIONS COUNTRY PROGRAMMES 0 548000 VACCINE SUPPORT FMV SOUTH ASIA COUNTRY PROGRAMMES 22317427 BOARD APPROVAL/WIRE TRANSFER 43767937 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 187464 BOARD APPROVAL/WIRE TRANSFER 509433470 VACCINE SUPPORT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 0 10215813 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 7638271 BOARD APPROVAL/WIRE TRANSFER 129432419 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 230000 BOARD APPROVAL/WIRE TRANSFER 457844 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 231917 BOARD APPROVAL/WIRE TRANSFER 6947503 VACCINE SUPPORT FMV EUROPE (INCLUDING ICELAND & GREENLAND) COUNTRY PROGRAMMES 460000 BOARD APPROVAL/WIRE TRANSFER 5458281 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 1379581 BOARD APPROVAL/WIRE TRANSFER 22115062 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 3858469 BOARD APPROVAL/WIRE TRANSFER 30218530 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 395826 BOARD APPROVAL/WIRE TRANSFER 23716712 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2601819 BOARD APPROVAL/WIRE TRANSFER 21989575 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 0 354000 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 9553250 BOARD APPROVAL/WIRE TRANSFER 33004124 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2444137 BOARD APPROVAL/WIRE TRANSFER 27046956 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 460000 BOARD APPROVAL/WIRE TRANSFER 9091587 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1849995 BOARD APPROVAL/WIRE TRANSFER 31039175 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1118964 BOARD APPROVAL/WIRE TRANSFER 15852808 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 0 97200 VACCINE SUPPORT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 737944 BOARD APPROVAL/WIRE TRANSFER 6793373 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 460000 BOARD APPROVAL/WIRE TRANSFER 4669071 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 9477259 BOARD APPROVAL/WIRE TRANSFER 95458651 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV EUROPE (INCLUDING ICELAND & GREENLAND) COUNTRY PROGRAMMES 122400 BOARD APPROVAL/WIRE TRANSFER 20201527 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 230000 BOARD APPROVAL/WIRE TRANSFER 5680 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 314600 BOARD APPROVAL/WIRE TRANSFER 41730510 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 0 56400 VACCINE SUPPORT FMV SOUTH ASIA COUNTRY PROGRAMMES 10082859 BOARD APPROVAL/WIRE TRANSFER 373304516 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 350000 BOARD APPROVAL/WIRE TRANSFER 31080449 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 15066758 BOARD APPROVAL/WIRE TRANSFER 134069373 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 65624713 BOARD APPROVAL/WIRE TRANSFER 588721272 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV SOUTH ASIA COUNTRY PROGRAMMES 79413779 BOARD APPROVAL/WIRE TRANSFER 678854949 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 1230000 BOARD APPROVAL/WIRE TRANSFER 38053186 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1017057 BOARD APPROVAL/WIRE TRANSFER 6237229 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 9420308 BOARD APPROVAL/WIRE TRANSFER 386201045 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 3999764 BOARD APPROVAL/WIRE TRANSFER 85428797 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 430000 BOARD APPROVAL/WIRE TRANSFER 47944385 VACCINE SUPPORT FMV CENTRAL AMERICA AND THE CARIBBEAN COUNTRY PROGRAMMES 430000 BOARD APPROVAL/WIRE TRANSFER 170946 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 0 973685 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 1379371 BOARD APPROVAL/WIRE TRANSFER 990035 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2854634 BOARD APPROVAL/WIRE TRANSFER 24612815 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 0 10500 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2060353 BOARD APPROVAL/WIRE TRANSFER 17832412 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 587837 BOARD APPROVAL/WIRE TRANSFER 3586845 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 12248254 BOARD APPROVAL/WIRE TRANSFER 38598296 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 1967200 BOARD APPROVAL/WIRE TRANSFER 26458948 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 9819623 BOARD APPROVAL/WIRE TRANSFER 8422132 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 21367796 BOARD APPROVAL/WIRE TRANSFER 85688632 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 2927725 BOARD APPROVAL/WIRE TRANSFER 87606898 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 2727185 BOARD APPROVAL/WIRE TRANSFER 33030587 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 7180892 BOARD APPROVAL/WIRE TRANSFER 136434911 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 267015 BOARD APPROVAL/WIRE TRANSFER 8398835 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 4236200 BOARD APPROVAL/WIRE TRANSFER 34183588 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 460000 BOARD APPROVAL/WIRE TRANSFER 409484 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 1046736 BOARD APPROVAL/WIRE TRANSFER 52248905 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 460000 BOARD APPROVAL/WIRE TRANSFER 54204 VACCINE SUPPORT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 9687905 BOARD APPROVAL/WIRE TRANSFER 226183131 VACCINE SUPPORT, COLD CHAIN EQUIPMENT, YELLOW FEVER DIAG. FMV EUROPE (INCLUDING ICELAND & GREENLAND) COUNTRY PROGRAMMES 4033435 BOARD APPROVAL/WIRE TRANSFER 113632078 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV RUSSIA AND NEIGHBORING STATES COUNTRY PROGRAMMES 4648133 BOARD APPROVAL/WIRE TRANSFER 200524166 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 460000 BOARD APPROVAL/WIRE TRANSFER 554836 VACCINE SUPPORT FMV EAST ASIA AND THE PACIFIC COUNTRY PROGRAMMES 1216997 BOARD APPROVAL/WIRE TRANSFER 261304043 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV MIDDLE EAST AND NORTH AFRICA COUNTRY PROGRAMMES 10539364 BOARD APPROVAL/WIRE TRANSFER 33499365 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 4590014 BOARD APPROVAL/WIRE TRANSFER 67334665 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV SUB-SAHARAN AFRICA COUNTRY PROGRAMMES 2158812 BOARD APPROVAL/WIRE TRANSFER 34921656 VACCINE SUPPORT FMV VARIOUS REGIONS COUNTRY PROGRAMMES 141403436 BOARD APPROVAL/WIRE TRANSFER 313215371 VACCINE SUPPORT, COLD CHAIN EQUIPMENT FMV EAST ASIA AND THE PACIFIC WORK PLAN 4415004 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 181581 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 15236 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 672140 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 551298 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 307731 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 90000 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 32258 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 177208 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 200621 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 704798 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 415313 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 2938912 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 75829 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 123618 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 37597 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 218375 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 288406 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 25396 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 67403 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 174079 BOARD APPROVAL/WIRE TRANSFER 0 SOUTH ASIA WORK PLAN 692597 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 193436 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 141426 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 173769 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 1300000 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 304558 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 84070 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 55142 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 162800 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 45874 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 464842 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 314075 BOARD APPROVAL/WIRE TRANSFER 0 SOUTH ASIA WORK PLAN 68911 BOARD APPROVAL/WIRE TRANSFER 0 SOUTH ASIA WORK PLAN 166933 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 138638 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 154012 BOARD APPROVAL/WIRE TRANSFER 0 SOUTH ASIA WORK PLAN 850738 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 1080459 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 233517 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 553560 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 25998 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 311236 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 65520 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 552938 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 26599 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 151091 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 12788 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 512538 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 260866 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 4055471 BOARD APPROVAL/WIRE TRANSFER 0 SOUTH ASIA WORK PLAN 26536 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 403391 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 319058 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 43074 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 7171 BOARD APPROVAL/WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC WORK PLAN 1000000 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 1382300 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 342621 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 100031 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 18910 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 2792664 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 385596 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 497272 BOARD APPROVAL/WIRE TRANSFER 0 SOUTH ASIA WORK PLAN 1234449 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 233402 BOARD APPROVAL/WIRE TRANSFER 0 SOUTH ASIA WORK PLAN 4652750 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 33300000 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 352637 BOARD APPROVAL/WIRE TRANSFER 0 SUB-SAHARAN AFRICA WORK PLAN 105042 BOARD APPROVAL/WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) WORK PLAN 64325034 BOARD APPROVAL/WIRE TRANSFER 0 24 148 1 0 0 0 0 1 PART I, LINE 2: GAVI MONITORS THE USE OF GRANT SUPPORT AND PROTECTS AGAINST CORRUPTION AND FRAUD THROUGH COLLABORATION WITH PARTNERS, THROUGH THE MAINTENANCE AND IMPLEMENTATION OF ROBUST POLICIES AND PROCEDURES, GRANT TERMS AND CONDITIONS, AND AN AUDIT AND INVESTIGATIONS FUNCTION. POLICIES AND PROCEDURES: ALL APPLICATIONS FOR NEW SUPPORT, AND REQUESTS FOR CONTINUED SUPPORT, REQUIRE AN ENDORSEMENT AND SIGNATURES FROM A NATIONAL COORDINATION BODY WHICH IN THE CASE OF NEW VACCINES SUPPORT, IS THE INTER-AGENCY COORDINATION COMMITTEE (ICC). THE ICC INCLUDES ON ITS MEMBERSHIP, IN ADDITION TO HIGH LEVEL REPRESENTATION OF THE GOVERNMENT OF GAVI COUNTRIES, GAVI PARTNERS SUCH AS THE WORLD HEALTH ORGANIZATION, UNICEF, NONGOVERNMENTAL ORGANIZATIONS AND DONOR GOVERNMENTS. IN THE CASE OF CASH SUPPORT FOR HEALTH SYSTEM STRENGTHENING, ENDORSEMENT IS REQUIRED FROM THE HEALTH SECTOR COORDINATION COMMITTEE (HSCC) OR OTHER SIMILAR INTER-AGENCY COMMITTEE WHICH ALSO INCLUDES THE GOVERNMENT, BILATERAL, MULTILATERAL AGENCIES AND CIVIL SOCIETY REPRESENTATIVES. IN ADDITION, THE APPLICATIONS SUBMITTED MUST INCLUDE THE SIGNATURES OF THE MINISTER OF HEALTH AND THE MINISTER OF FINANCE. THE GAVI NEW APPLICATIONS GUIDELINES PROVIDE DETAILS ON GAVI SUPPORT, INCLUDING GENERAL PRINCIPLES AND THE PROCESS FOR APPLYING AND MONITORING ACTIVITIES. A PARTNERSHIP FRAMEWORK AGREEMENT IS ENTERED INTO BETWEEN GAVI AND COUNTRIES THAT SETS OUT THE TERMS AND CONDITIONS GOVERNING GAVI SUPPORT. THE MAIN TOOLS/APPROACHES USED BY GAVI TO MONITOR THE USE OF GAVI SUPPORT ARE THE FOLLOWING: (1) IN-COUNTRY COORDINATING AND SUPERVISORY COMMITTEES (ICC AND HSCC); (2) ROUTINE MONITORING MISSIONS IN-COUNTRY, LED BY SENIOR COUNTRY MANAGERS, WORKING WITH PARTNERS AND IN-COUNTRY COUNTERPARTS AS WELL AS FORMAL ANNUAL JOINT APPRAISALS THAT REVIEW PERFORMANCE OF ALL GRANTS IN-COUNTRY; (3) FOR CASH GRANTS - RISK-BASED PROGRAMME AUDITS AND PERIODIC EXTERNAL AUDITS ON TOP OF ROUTINE FINANCIAL REPORTING REQUIREMENTS; (4) THE PROGRAMME CAPACITY ASSESSMENTS THAT INDEPENDENTLY ASSESS FINANCIAL MANAGEMENT ARRANGEMENTS AND PROGRAMMATIC/MANAGEMENT CAPACITIES IN-COUNTRY AS WELL AS INVESTIGATIONS IN CASES OF SUSPECTED OR ACTUAL MISUSE OF FUNDS; AND (5) ROUTINE QUANTITATIVE AND QUALITATIVE REPORTING THROUGH GRANT PERFORMANCE FRAMEWORKS, REQUIRED REPORTS/EVALUATIONS/SURVEYS/ASSESSMENTS SUBMITTED TO GAVI BY RECIPIENT GOVERNMENTS AND ASSESSED BY THE HIGH-LEVEL REVIEW PANEL/SENIOR MANAGEMENT. COLLABORATION WITH PARTNERS: GAVI MAINTAINS FORMAL AND INFORMAL CONTACT WITH THE PARTNERS (THE BILL & MELINDA GATES FOUNDATION, UNICEF, WHO, THE WORLD BANK GROUP, CIVIL SOCIETY ORGANIZATIONS, DEVELOPING COUNTRY GOVERNMENTS, DEVELOPING COUNTRY PHARMACEUTICAL INDUSTRY, INDUSTRIALISED COUNTRY GOVERNMENTS, INDUSTRIALISED COUNTRY PHARMACEUTICAL INDUSTRY, RESEARCH AND TECHNICAL HEALTH INSTITUTES) AT VARIOUS LEVELS TO HELP ENSURE THAT RELEVANT INFORMATION ABOUT SUSPECTED AND ACTUAL CASES OF CORRUPTION AND MISUSE OF FUNDS IS SHARED ON A TIMELY BASIS. GAVI ENGAGES UNICEF, A KEY PARTNER IN GAVI, THE VACCINE ALLIANCE, FOR THE PURCHASE AND DELIVERY OF VACCINES. UNICEF MANAGES VACCINE LOGISTICS AND DELIVERY IN ACCORDANCE WITH ITS INTERNAL CONTROLS AND INTERNAL AND EXTERNAL AUDITS AS MANDATED BY ITS MEMBER STATES. GAVI AND UNICEF HAVE ENTERED INTO VARIOUS AGREEMENTS WHICH PROVIDE FOR CONFIRMATIONS, ASSURANCES AND INFORMATION REGARDING UNICEF ACTIVITIES CARRIED OUT ON BEHALF OF THE ALLIANCE. AUDIT AND INVESTIGATIONS: THE PRIMARY RESPONSIBILITY OF THE AUDIT AND INVESTIGATIONS FUNCTION IS TO EVALUATE AND STRENGTHEN RISK MANAGEMENT, INTERNAL CONTROL AND GOVERNANCE PROCESSES IN THE ORGANIZATION. THE WORK OF AUDIT AND INVESTIGATIONS EXTENDS NOT ONLY TO THE SECRETARIAT, BUT ALSO TO THE PROGRAMS AND ACTIVITIES OF GAVI'S GRANT RECIPIENTS, PARTNERS AND THE FACILITY. AUDIT AND INVESTIGATIONS IS LED BY A MANAGING DIRECTOR WHO REPORTS TO THE GAVI BOARD, THROUGH ROUTINE REPORTING TO THE AUDIT AND FINANCE COMMITTEE, AND TO THE CHIEF EXECUTIVE OFFICER. THE BOARD OF DIRECTORS SOLELY HAS THE AUTHORITY TO APPOINT AND TERMINATE THE MANAGING DIRECTOR OF AUDIT AND INVESTIGATIONS UPON THE RECOMMENDATION OF THE AUDIT AND FINANCE COMMITTEE. THE TRANSPARENCY AND ACCOUNTABILITY POLICY (TAP): THROUGH TAP, GAVI IS ABLE TO ENSURE THAT ALL GAVI SUPPORT AT COUNTRY LEVEL IS MANAGED IN A TRANSPARENT AND ACCOUNTABLE MANNER THROUGH SYSTEMS THAT INCLUDE APPROPRIATE OVERSIGHT MECHANISMS, AND THAT THE SUPPORT IS USED ACCORDING TO THE PROGRAMME OBJECTIVES AS OUTLINED IN INDIVIDUAL COUNTRY AGREEMENTS. THE POLICY GOVERNS THE TRANSPARENCY AND ACCOUNTABILITY ASPECTS OF GAVI SUPPORT PROVIDED IN THE FORM OF CASH, VACCINES AND VACCINE DEVICES AT COUNTRY LEVEL. THE PRINCIPLES GOVERNING TAP INCLUDE: RESPECT AID EFFECTIVENESS PRINCIPLES; FOCUS ON PREVENTION; RELATE MONITORING TO RISK; PROMOTE FLEXIBILITY AND COUNTRY OWNERSHIP; PROMOTE MUTUAL ACCOUNTABILITY; AND STRENGTHEN COUNTRY SYSTEMS. TAP AIMS TO RETAIN FLEXIBLE AND NON-PERSPECTIVE APPROACH TO ALLOW FOR DIFFERENCES IN COUNTRY CONTEXT AND ENHANCES CONTINUED EFFORTS BY GAVI TO SUPPORT SUSTAINABLE DEVELOPMENT OF COUNTRY CAPACITY. PART I, LINE 3: THE ALLIANCE REPORTED THE EXPENDITURES BASED ON THE ACCOUNTING METHOD USED IN ITS AUDITED FINANCIAL STATEMENTS WHICH IS ON AN ACCRUAL BASIS. PART III ACCOUNTING METHOD: PART I, LINE 3, COLUMN (D) RECIPIENTS REFER TO COUNTRIES OR PARTNERS LOCATED IN THE REGION. PART II, LINE 1 THE ALLIANCE REPORTED THE EXPENDITURES BASED ON THE ACCOUNTING METHOD USED IN ITS AUDITED FINANCIAL STATEMENTS WHICH IS ON AN ACCRUAL BASIS. 1 ALBERT B SABIN VACCINE INSTITUTE 2000 PENSYLVANIA AVENUE NW SUITE 7100 WASHINGTON DC DC 20006 061389829 501(C)(3) 234435 0 PARTNER SUPPORT CDC 1600 CLIFTON ROAD ATLANTA GA 30303 586051157 CDC 1339135 0 PARTNER SUPPORT CDC FOUNDATION 600 PEACHTREE ST NE SUITE 1000 ATLANTA GA 30303 582106707 501(C)(3) 3553308 0 PARTNER SUPPORT CLINTON HEALTH ACCESS INITIATIVE 383 DORCHESTER AVENUE SUITE 400 BOSTON MA 02127 271414646 501(C)(3) 4018541 0 PARTNER SUPPORT FRAYM INC 3101 WILSON BLVD SUITE 300 ARLINGTON VA 22201 813857001 67500 0 PARTNER SUPPORT INTERNATIONAL ORGANISATION FOR MIGRANTS 399 PARK AVENUE NEW YORK NY 10022 349000 0 PARTNER SUPPORT HARVARD - PRESIDENT AND FELLOWS OF HARVARD COLLEGE 1033 MASSACHUSSETS AVENUE CAMBRIDGE MA 02138 042103580 501(C)(3) 51505 0 PARTNER SUPPORT JHPIEGO 1615 THAMES STREET BALTIMORE MD 21231 237424444 501(C)(3) 299137 0 PARTNER SUPPORT JOHNS HOPKINS UNIVERSITY 1101 E33RD STREET SUITE D200 BALTIMORE MD 21218 520595110 501(C)(3) 887517 0 PARTNER SUPPORT JSI RESEARCH & TRAINING INSTITUTE INC 2733 CRYSTAL DRIVE 4TH FLOOR ARLINGTON VA 22202 042679824 501(C)(3) 4345616 0 PARTNER SUPPORT KANTAR LLC 3333 WARRENVILLE ROAD SUITE 400 LISLE IL 60532 813314059 489812 0 PARTNER SUPPORT KATI COLLECTIVE INC 13346 108TH AVENUE SW VASHON WA 98070 843168072 222931 0 PARTNER SUPPORT MASTERCARD INTERNATIONAL INC 200 PURCHASE STREET PURCHASE NEW YORK NY 10577 952536378 565445 0 PARTNER SUPPORT NEXLEAF ANALYTICS 1964 WESTWOOD BLVD LOS ANGELES CA 90025 900514027 501(C)(3) 648511 0 PARTNER SUPPORT PAN AMERICAN SANITARY BUREAU 525 TWENTY-THIRD STEET NW WASHINGTON DC DC 20037 521804954 PASB 7009203 0 PARTNER SUPPORT PARSYL INC 2714 WALNUT STREET DENVER CO 80205 814027966 50000 0 PARTNER SUPPORT PATH 2201 WESTLAKE AVENUE SEATTLE WA 98109 911157127 501(C)(3) 3505710 0 PARTNER SUPPORT PREMISE DATA CORPORATION 185 BERRY STREET SUITE 6850 SAN FRANCISCO CA 94107 455294131 658341 0 PARTNER SUPPORT RESULTS FOR DEVELOPMENT INSTITUTE 1111 19TH STREET NW SUITE 700 WASHINGTON DC DC 20036 208530747 501(C)(3) 407299 0 PARTNER SUPPORT THE DIFFERENCE A2C LLC 661 AUBURN AVENUE NE SUITE 5 ATLANTA GA 30312 261133788 77700 0 PARTNER SUPPORT THE ASPEN INSTITUTE 2300 N STREET NW SUITE 700 WASHINGTON DC DC 20037 840399006 501(C)(3) 72536 0 PARTNER SUPPORT THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 615 WEST 131ST STREET NEW YORK NY 10027 135598093 811984 0 PARTNER SUPPORT THE WORLD BANK (IBRD) 1818 H STREET WASHINGTON DC DC 20433 980002549 THE WORLD BANK 4119045 0 PARTNER SUPPORT UNICEF 333 EAST 38TH STREET NEW YORK NY 10116 131760110 501(C)(3) 56708099 0 PROCUREMENT FEE & PARTNER SUPPORT VILLAGE REACH 2900 EASTLAKE AVE E SUITE 230 SEATTLE WA 98102 912083484 501(C)(3) 1163523 0 PARTNER SUPPORT YALE UNIVERSITY PO BOX 1873 NEW HAVEN CT 06508 060646973 501(C)(3) 312980 0 PARTNER SUPPORT ZENYSIS TECHNOLOGIES INC 2325 3RD ST NUMBER 213 SAN FRANCISCO CA 94107 810929294 1504972 0 PARTNER SUPPORT JOHN SNOW INC 44 FARNSWORTH STREET BOSTON MA 02210 042578580 168307 0 PARTNER SUPPORT 15 13 PART I, LINE 2: GAVI MONITORS THE USE OF GRANT FUNDS MADE TO ENTITIES INSIDE THE US AND SUBSEQUENTLY DISBURSED IN GAVI PROGRAMME COUNTRIES AS DESCRIBED IN SCHEDULE F, PART V. ANY GRANT FUNDS MADE TO ENTITIES INSIDE THE US AND USED INSIDE THE US ARE MONITORED THROUGH THE FOLLOWING WAYS: (I) THROUGH, AT MINIMUM, ANNUAL TECHNICAL PROGRESS REPORTS AND CERTIFIED FINANCIAL REPORTS FROM GRANTEES THAT SUPPORT THE ACHIEVEMENT OF MILESTONES STIPULATED IN THE GRANT AGREEMENTS. REPORTS ARE RECEIVED AND REVIEWED BY THE GAVI STAFF BUSINESS OWNER; AND (II) ARE SUBJECT TO GAVI INTERNAL AUDIT AS APPROPRIATE. X X 1 1 X X X 1 0 0 0 0 0 0 0 0 DR SETH BERKLEY CHIEF EXECUTIVE OFFICER 429115 0 4248 0 263102 0 96702 0 21272 0 814439 0 0 0 ANURADHA GUPTA DEPUTY CHIEF EXECUTIVE OFFICER 340948 0 6819 0 0 0 76833 0 11501 0 436101 0 0 0 SIMON LAMB MNG DIR, AUDIT & INVESTIGATIONS 282041 0 5641 0 0 0 63558 0 10774 0 362014 0 0 0 PASCAL BAROLLIER MANAGING DIR, PUBLIC ENGAGEMENT & IS 267240 0 2646 0 0 0 59970 0 26934 0 356790 0 0 0 ALEX DE FAUQUE DE JONQUIERES DIR, HEALTH SYS. & IMMUNE. STRENGTH. 232877 0 2305 0 52906 0 51041 0 14630 0 353759 0 0 0 EDMUND GROVE DIRECTOR PROGRAMME AUDIT 226355 0 2241 0 52906 0 49375 0 14630 0 345507 0 0 0 ANDREW MENDS DIRECTOR OPERATIONS 225265 0 2230 0 52906 0 49038 0 14630 0 344069 0 0 0 MARIE-ANGE SARAKA-YAO MNG DIR, RESOURCE MOBL./PARTNERSHIPS 273464 0 2708 0 0 0 61626 0 5387 0 343185 0 0 0 AURELIA NGUYEN MNG DIR OFFICE OF THE COVAX FACILITY 269871 0 2664 0 0 0 60643 0 9243 0 342421 0 0 0 ANTHONY BROWN SENIOR LEGAL COUNSEL - UNTIL 05/2021 75120 0 1800 0 233875 0 15785 0 3476 0 330056 0 0 0 THABANI MAPHOSA MANAGING DIR, COUNTRY PROGRAMMES 223457 0 2212 0 26453 0 48577 0 18425 0 319124 0 0 0 BRENDA KILLEN DIRECTOR, GOVERNANCE 204944 0 1186 0 52906 0 43809 0 14630 0 317475 0 0 0 ASSIETOU DIOUF MANAGING DIR, FINANCE & OPERATIONS 231997 0 2297 0 0 0 50849 0 21547 0 306690 0 0 0 PART I, LINE 1A UNDER AN AGREEMENT WITH THE SWISS GOVERNMENT, NON-SWISS EMPLOYEES OF THE GAVI ALLIANCE WORKING IN GENEVA, SWITZERLAND ARE EXEMPT FROM SWISS FEDERAL, CANTONAL AND COMMUNAL TAXES ON SALARIES AND ALLOWANCES PAID TO THEM BY THE GAVI ALLIANCE. AS THE GAVI ALLIANCE IN GENEVA OPERATES AN INTERNAL TAX SCHEME, EMPLOYEES OF SWISS NATIONALITY ARE ALSO EXEMPT FROM SWISS FEDERAL, CANTONAL AND COMMUNAL TAXES ON SALARIES AND ALLOWANCES PAID TO THEM BY THE GAVI ALLIANCE. TO ENSURE EQUITY AMONGST GAVI EMPLOYEES, CERTAIN ELIGIBLE EMPLOYEES WHO HAVE A FOREIGN TAX LIABILITY ON THEIR GAVI SALARY AND ALLOWANCES (E.G. US NATIONALS AND EMPLOYEES LIVING IN FRANCE) MAY RECEIVE ASSISTANCE FROM GAVI IN MEETING THEIR TAX OBLIGATIONS IN ACCORDANCE WITH GAVI'S FOREIGN TAX POLICY. IN ADDITION, FOR THE YEAR ENDED DECEMBER 31, 2021, THE CHIEF EXECUTIVE OFFICER RECEIVED A HOUSING ALLOWANCE WHICH WAS TREATED AS TAXABLE COMPENSATION. PART I, LINE 4A ANTHONY BROWN, SENIOR LEGAL COUNCIL, RECEIVED A SEVERANCE PAYMENT OF $210,566 DURING THE YEAR ENDED DECEMBER 31, 2021. SCHEDULE J, PART II, COLUMN (B)(III): OTHER REPORTABLE COMPENSATION - THIS INCLUDES ALLOWANCES DUE TO EMPLOYEES UNDER GAVI'S HR POLICY, INCLUDING ALLOWANCES FOR RELOCATION, EDUCATION GRANT AND REIMBURSEMENT OF NON-SWISS TAXES ON GAVI INCOME. SCHEDULE J, PART II: GAVI REPORTED COMPENSATION ALL VALUES IN SWISS FRANCS (CHF) A B C D E F G BONUS OTHER REPORTED COMP RETIRE NONTAX BASE AND TAX EDU MENT ABLE COMP INC REIMB GRANT BENEFITS PLAN HEALTH INS DR. SETH BERKLEY 2020 388,682 15,394 136,189 48,400 18,000 87,590 19,460 2021 392,567 3,887 174,293 48,400 18,000 88,466 19,460 BRENDA KILLEN 2020 108,285 0 0 48,400 0 23,147 7,807 2021 187,489 1,085 0 48,400 0 40,078 13,384 ASSIETOU DIOUF 2020 210,423 0 0 0 0 46,057 19,712 2020 212,237 2,102 0 0 0 46,518 19,712 ANURADHA GUPTA 2020 311,909 15,595 0 0 0 70,289 9,856 2021 311,909 6,238 0 0 0 70,289 10,521 THABANI MAPHOSA 2020 202,403 0 0 48,400 0 44,000 13,384 2021 204,425 2,024 0 24,200 0 44,440 16,856 PASCAL BAROLLIER 2020 242,397 0 0 0 0 54,319 21,784 2021 244,479 2,421 0 0 0 54,862 24,640 MARIE-ANGE SARAKA-YAO 2020 248,042 0 0 0 0 55,818 4,928 2021 250,173 2,477 0 0 0 56,377 4,928 AURELIA NGUYEN 2020 244,778 0 0 0 0 54,929 8,456 2021 246,886 2,437 0 0 0 55,478 8,456 SIMON LAMB 2020 258,020 5,160 0 0 0 58,146 9,856 2021 258,020 5,160 0 0 0 58,145 9,856 ALEX DE FAUQUE DE JONQUIERES 2020 211,221 0 0 48,400 0 46,232 13,384 2021 213,043 2,109 0 48,400 0 46,694 13,384 EDMUND GROVE 2020 205,444 0 0 48,400 0 44,723 13,384 2021 207,076 2,050 0 48,400 0 45,170 13,384 ANDREW MENDS 2020 204,320 0 0 48,400 0 44,417 13,384 2021 206,079 2,040 0 48,400 0 44,861 13,384 ANTHONY BROWN 2021 278,234* 1,646 4,444 0 0 14,441 3,180 * THIS AMOUNT INCLUDES SEVERANCE PAYMENT AND PAID HOLIDAYS. THE CHF-USD EXCHANGE RATE IS 1.07120 IN 2020 AND 1.0931 IN 2021 THE FULL TEXT OF THE ABBREVIATED HEADINGS IN THE TABLE ABOVE ARE AS FOLLOWS: A - BASE COMPENSATION B - BONUS AND INCENTIVE "OTHER REPORTED COMPENSATION" INCLUDES THE FOLLOWING: C - US TAX REIMBURSEMENT D - EDUCATION GRANT E - OTHER BENEFITS F - RETIREMENT PLAN G - NON-TAXABLE HEALTH INSURANCE SCHEDULE J, PART III: ALL OF GAVI ALLIANCE'S HIGHEST COMPENSATED EMPLOYEES ARE BASED IN GENEVA, SWITZERLAND. THESE EMPLOYEES' SALARIES REFLECTED THE COST OF LIVING IN GENEVA AND INCLUDE BENEFITS SUCH AS EDUCATION GRANT. THE BENEFITS PROVIDED TO EMPLOYEES ARE COMPARABLE TO THOSE PROVIDED BY OTHER INTERNATIONAL NOT-FOR-PROFIT ORGANISATIONS. X 5 274800 FMV X 592967865 4406449191 FMV 0 1 0 PART I, COLUMN (B): GAVI REPORTS THE NUMBER OF ITEMS CONTRIBUTED IN PART I, COLUMN (B), LINE 6 AND NUMBER OF DOSES IN LINE 20. FORM 990, BOX 5 GAVI IS AN INDEPENDENT NON-PROFIT FOUNDATION WITHIN THE MEANING OF ARTICLES 80 ET SEQ. OF THE SWISS CIVIL CODE. IT IS REGISTERED AT THE REGISTRY OF COMMERCE OF THE CANTON OF GENEVA AND PLACED UNDER THE SUPERVISION OF THE SWISS SUPERVISORY BOARD FOR FOUNDATIONS. FORM 990, PART I, LINE 5 PART I, LINE 5 LISTS THE TOTAL NUMBER OF EMPLOYEES WHO RECEIVED THE FORM W-2, AND IT DOES NOT INCLUDE FOREIGN EMPLOYEES IN GENEVA, SWITZERLAND. THE TOTAL NUMBER OF EMPLOYEES INCLUDING THE FOREIGN EMPLOYEES IS 318. FORM 990, PART VI, SECTION B, LINE 11B THE OUTSOURCED ACCOUNTANT (OA), IN COLLABORATION WITH THE SENIOR MANAGER OF FINANCIAL REPORTING, GATHERS ALL INFORMATION NEEDED TO PREPARE THE FEDERAL FORM 990 FROM THE RESPECTIVE GAVI DEPARTMENTS. OA THEN PREPARES THE DRAFT FEDERAL FORM 990 AND PROVIDES IT TO THE GAVI HEAD OF FINANCIAL REPORTING, ACCOUNTING AND CONTROLLING (HFRAC) FOR REVIEW. THE HFRAC REVIEWS THE DRAFT FEDERAL FORM 990 AND DISCUSSES ANY NECESSARY CHANGES WITH THE OA AND SENIOR MANAGER. THE OA THEN SUBMITS THE DRAFT FEDERAL FORM 990 TO THE TAX FIRM FOR REVIEW AND DISCUSSES ANY NECESSARY UPDATES PROVIDED BY THE TAX FIRM, AFTER WHICH THE DRAFT FEDERAL FORM 990 IS UPDATED BY THE OA. THE SENIOR MANAGER THEN CIRCULATES THE UPDATED DRAFT FEDERAL FORM 990 TO VARIOUS GAVI TEAMS FOR THEIR REVIEW AND COMMENT. THE DRAFT FEDERAL FORM 990 IS UPDATED FOR COMMENTS RECEIVED AS DEEMED NECESSARY BY THE HFRAC. THE DRAFT FEDERAL FORM 990, INCLUDING ALL REQUIRED SCHEDULES, IS PROVIDED TO THE AUDIT AND FINANCE COMMITTEE. A GAVI AUTHORIZED REPRESENTATIVE SIGNS THE FEDERAL FORM 990 AFTER WHICH IT IS FILED WITH THE INTERNAL REVENUE SERVICE. FORM 990, PART VI, SECTION B, LINE 12C THE GOVERNANCE TEAM CIRCULATES THE CONFLICT OF INTEREST DISCLOSURE FORMS TO THE BOARD MEMBERS ANNUALLY. GOVERNANCE MONITORS DISCLOSURE FORMS BY COLLECTING ALL CONFLICT OF INTEREST DISCLOSURES FROM BOARD MEMBERS. THE POLICY IS MONITORED BY THE BOARD OF DIRECTORS ITSELF, AND RELEVANT CONFLICTS ARE DISCLOSED AT THE BOARD OF DIRECTORS MEETINGS AND NOTED IN THE MINUTES. DECLARATIONS OF INTERESTS OF PARTICIPATING BOARD AND COMMITTEE MEMBERS ARE ALSO SHARED AS PART OF THE ADVANCE MATERIAL FOR EACH MEETING. A BOARD MEMBER/ALTERNATE BOARD MEMBER OR COMMITTEE DELEGATE IS EXPECTED TO DISCLOSE ANY REAL/PERCEIVED OR POTENTIAL CONFLICT TO THE CHAIR OF THE BOARD OR THE COMMITTEE, AS SOON AS POSSIBLE UPON LEARNING OF IT AND NO LATER THAN AT THE BEGINNING OF THE DISCUSSION OF THE PERTINENT AGENDA ITEM DURING A BOARD/COMMITTEE MEETING. IT IS THE PREROGATIVE OF THE CHAIR OF THE MEETING, IN CONSULTATION WITH THE DIRECTOR OF LEGAL OR GOVERNANCE, TO DETERMINE THE SCOPE AND LEVEL OF A CONFLICTED PERSON'S PARTICIPATION IN THE DISCUSSION AND THE NECESSITY OF RECUSAL FROM VOTING GIVEN THE TYPE OF INTEREST DISCLOSED. RECUSALS AND/OR ABSTENTIONS FROM ANY DISCUSSIONS AND VOTES ARE NOTED IN THE MINUTES OF THE RELEVANT MEETING. FORM 990, PART VI, SECTION B, LINE 15 GAVI'S COMPENSATION AIMS TO ATTRACT, ENGAGE, REWARD AND RETAIN A TEAM OF HIGH PERFORMING EMPLOYEES WHO ARE DEDICATED TO GAVI'S MISSION. IN 2008, THE GAVI BOARD APPROVED GAVI'S COMPENSATION AND BENEFIT FRAMEWORK. A REVIEW OF THE GAVI SALARY SCALE WAS CONDUCTED IN 2013-2014 BY MERCER, AN INDEPENDENT GLOBAL FIRM SPECIALIZED IN THE FIELD OF COMPENSATION, AND BENCHMARKED AGAINST A COMPOSITE PEER MARKET. THE REVIEW CONCLUDED THAT GAVI'S SALARY SCALE POSITIONING WAS IN ALIGNMENT WITH MARKET AND PEERS. IN 2018, A FURTHER REVIEW WAS UNDERTAKEN BY MERCER. GAVI'S SALARY SCALE HAS NOT CHANGED SINCE ITS INTRODUCTION IN 2008. UPON HIRING, OFFICERS AND KEY EMPLOYEES AT GAVI ARE PLACED WITHIN THE SCALE. FORM 990, PART VI, SECTION C, LINE 19 GOVERNANCE DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE POSTED ON THE GAVI ALLIANCE WEBSITE. FORM 1023 AND FEDERAL FORM 990 ARE MADE AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST. FORM 990, PART VII, SECTION A AN ALTERNATE MEMBER CAN VOTE ONLY WHEN THE CORRESPONDING PRIMARY BOARD MEMBER IS UNABLE TO PARTICIPATE IN VOTING. IF THE PRIMARY BOARD MEMBER IS ABLE TO SUBMIT HIS/HER VOTE THEN THE ALTERNATE MEMBER'S VOTE IS NOT REQUIRED. PART VII LISTS 44 VOTING BOARD MEMBERS. HOWEVER ONLY 26 VOTES COULD BE CAST WHICH ARE PRINCIPAL BOARD MEMBERS. THE 18 ALTERNATE BOARD MEMBERS COULD NOT VOTE UNLESS THEIR ASSOCIATED PRINCIPAL BOARD MEMBER WAS UNAVAILABLE TO VOTE. NONE OF THE ALTERNATE BOARD MEMBER SEATS WERE VACANT. FORM 990, PART XI, LINE 9: RETURN OF UNSPENT FUNDS 6,230,164. RECOVERY OF PRIOR YEAR GRANT 14,544,886. PROVISIONAL CONTRIBUTIONS RECEIVABLE -1,000,000. INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY 2 LAMBS PASSAGE LONDON EC1Y 8BB LONDON UK RAISES FUNDS FOR IMMUNIZATION PROGRAMS AND PROCUREMENT UK 501(C)(3) FOREIGN CHARITY GAVI ALLIANCE 1 IFFIM SUKUK COMPANY III LIMITED PO BOX 1093 QUEENSGATE HOUSE GRAND CAYMAN CJ KY1-1102 ISSUING SUKUK CERTIFICATES IN SUPPORT OF IFFIM'S OPERATIONS CJ INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY 1 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY C 1449477500 COST INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY N 191382 FMV INTERNATIONAL FINANCE FACILITY FOR IMMUNISATION COMPANY O 750242 FMV